Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Bisacodyl may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for
Bisacodyl 5 mg Tablets are used for the short-term relief of occasional constipation. Bisacodyl 5 mg Tablets contains bisacodyl and belongs to a group of medicines known as stimulant laxatives, which increase bowel movements. This medicine does not help with weight loss. What is constipation? Normal and regular bowel movement is important for most people. However, what is "normal and regular" varies from person to person. Some may have a bowel movement every day, others less often. Whatever it is like for you, it is best that your bowel movement has a regular pattern.
Whatever the cause, constipation can be uncomfortable. It may make you feel bloated and heavy or generally "off colour". Sometimes it causes headaches. It is recommended to use changes in diet and bulk forming medicines to control constipation before using this medicine. These healthy tips are recommended to try to prevent constipation happening:
e Bisacodyl 5 mg Tablets Do not take Bisacodyl 5 mg Tablets if you:
Other medicines and Bisacodyl 5 mg Tablets Please tell your pharmacist or doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. This includes herbal medicines. This is because Bisacodyl 5 mg Tablets can affect the way some other medicines work. Also, some other medicines can affect the way Bisacodyl 5 mg Tablets work. In particular, tell your doctor or pharmacist if you are taking:
Bisacodyl 5 mg Tablets Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Dose for oral tablets For constipation: Adults (including the elderly) and children over the age of 12 years: 1 to 2 tablets at night.
If you take more Bisacodyl 5 mg Tablets than you should If you take more of this medicine than you should, talk to a doctor or go to a hospital straight away. Take your medicine and this leaflet with you. This is so the doctor knows what you have taken. It may be harmful to:
Common side effects (affect less than 1 in 10 people)
not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Bisacodyl 5 mg Tablets Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and on the carton. The expiry date refers to the last day of that month. This medicinal product does not require any special storage conditions. Store in the original package in order to protect from moisture. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Bisacodyl 5 mg Tablets contain The active substance is bisacodyl. Bisacodyl 5 mg gastro-resistant tablets contain 5 mg of bisacodyl. The other ingredients are lactose monohydrate, maize starch, magnesium stearate, hypromellose, triacetin, talc, methacrylic acid and ethyl acrylate copolymer, triethyl citrate, titanium dioxide, colloidal anhydrous silica, sodium bicarbonate, sodium lauryl sulfate, macrogol and tartrazine (E102). What Bisacodyl 5 mg Tablets look like and the contents of the pack Bisacodyl 5 mg Tablets are yellow coloured, circular, biconvex, film coated tablets plain on both sides. They are available in foil blister packs of 40, 60 tablets and 100 tablets. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder Sovereign Medical, Sovereign House, Miles Gray Road, Basildon, Essex, SS14 3FR, UK Manufacturer Waymade Plc, Sovereign House, Miles Gray Road, Basildon, Essex, SS14 3FR, UK
This leaflet was last revised in May 2026 PL 06464/0186
Bisacodyl 5 mg Tablets
To request a copy of this leaflet in Braille, large print or audio format, contact the licence holder at the above address or telephone: 01268 535200 (select option Medical Information) / e-mail: [email protected]
Bisacodyl 5mg Tablets comes as tablet containing 5mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Bisacodyl 5mg Tablets is bisacodyl.
Medicines with the same active substance, strength and form include: Bisalax Constipation Relief 5mg Tablets Adult, Boots Constipation Relief 5mg Tablets Adult, Dulcolax Adult 5 mg Gastro-resistant Tablets (GSL). In total there are 6 equivalent products. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Bisacodyl 5mg Tablets, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
• For the short-term relief of occasional constipation.
Posology
Adults (including the elderly) and children over 12 years: 1 to 2 coated tablets (5 - 10 mg) daily before bedtime.
• Should not be used in children or adolescents under the age of 12 years.
It is recommended to start with the lowest dose. The dose may be adjusted up to the maximum recommended dose to produce regular stools. The maximum daily dose should not be exceeded.
In the management of constipation, once regularity has been restarted dosage should be reduced and can usually be stopped.
Method of administration
For oral use.
It is recommended to take the coated tablets at night to have a bowel movement the following morning. The tablets should be swallowed whole with an adequate amount of fluid.
The coated tablets should not be taken together with products which reduce the acidity of the upper gastrointestinal tract, such as milk, antacids or proton pump inhibitors, in order not to prematurely dissolve the enteric coating.
No specific information on the use of this product in the elderly is available. Clinical trials have included patients over 65 years and no adverse reactions specific to this age group have been reported.
Bisacodyl is contraindicated in patients with ileus, intestinal obstruction, acute abdominal conditions including appendicitis, acute inflammatory bowel diseases, and severe abdominal pain associated with nausea and vomiting which may be indicative of the aforementioned severe conditions.
Bisacodyl is also contraindicated in severe dehydration and in patients with known hypersensitivity to bisacodyl or any of the excipients listed in section 6.1.
In case of rare hereditary conditions that may be incompatible with an excipient of the product (please refer to “Special warnings and special precautions for use”) the use of the product is contraindicated.
i) As with all laxatives, bisacodyl should not be taken on a continuous daily basis for more than five days without investigating the cause of constipation.
ii) Long-term everyday use of stimulant laxatives may harm the intestinal function and should be avoided. If laxatives are needed every day the cause of the constipation should be investigated. This product should only be used if a therapeutic effect cannot be achieved by a change of diet or the administration of bulk forming agents.
iii) Prolonged excessive use may lead to fluid and electrolyte imbalance and hypokalaemia.
iv) Intestinal loss of fluids can promote dehydration. Symptoms may include thirst and oliguria. In patients suffering from fluid loss where dehydration may be harmful (e.g. renal insufficiency, elderly patients) bisacodyl should be discontinued and only be restarted under medical supervision.
v) Stimulant laxatives (including bisacodyl) do not help in long-term weight loss.
vi) Patients may experience haematochezia (blood in stool) that is generally mild and self-limiting.
vii) If the symptoms worsen during the use of the medicinal product, a doctor or pharmacist should be consulted.
Dizziness and / or syncope have been reported in patients who have taken bisacodyl. The details available for these cases suggest that the events would be consistent with defaecation syncope (or syncope attributable to straining at stool), or with a vasovagal response to abdominal pain related to the constipation, and not necessarily to the administration of bisacodyl itself.
There have been isolated reports of abdominal pain and bloody diarrhoea occurring after taking bisacodyl. Some cases have been shown to be associated with colonic mucosal ischaemia.
Should not be used in children under the age of 12 years.
The leaflet will state:
“Before you take this medicine” section
Does this help with weight loss?
Stimulant laxatives (including bisacodyl) do not help with weight loss. They do not reduce the absorption of calories or nutrients. They can cause watery stools (diarrhoea), abdominal cramps and dehydration. Dehydration can seem like weight loss.
Overuse of laxatives may damage your health by:
• Causing disturbances of electrolyte and mineral balances. Sodium, potassium, magnesium, and phosphorus are electrolytes and minerals that are present in very specific amounts necessary for proper functioning of the nerves and muscles, including those of the colon and heart. Upsetting this delicate balance can cause incorrect functioning of these vital organs.
• Severe dehydration may cause tremors, weakness, blurry vision, fainting, kidney damage, and, in extreme cases, death. Dehydration often requires medical treatment.
• Overuse of laxatives must be avoided as it may harm the intestinal function.
The labelling will state:
Front of pack:
• Does not help with weight loss.
• Overuse can be harmful.
This medicine contains lactose. Patients with rare hereditary problems of galactose or fructose intolerance, total lactase deficiency, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
Contains tartrazine (E102): May cause allergic reactions.
The concomitant use of antacids and milk containing products may reduce the resistance of the tablet coating and result in dyspepsia and gastric irritation.
The concomitant use of diuretics or adreno-corticosteroids may increase the risk of electrolyte imbalance if excessive doses of Bisacodyl are taken.
Electrolyte imbalance may lead to increased sensitivity to cardiac glycosides.
The concomitant use of other laxatives may enhance the gastrointestinal side effects of Bisacodyl.
Fertility
No studies on the effect on human fertility have been conducted.
Pregnancy
There are no adequate and well-controlled studies in pregnant women. Long experience has shown no evidence of undesirable or damaging effects during pregnancy.
Lactation
Clinical data show that neither the active moiety of bisacodyl (BHPM or bis-(p- hydroxyphenyl)-pyridyl-2-methane) nor its glucuronides are excreted into the milk of healthy lactating females.
Nevertheless, as with all medicines, Bisacodyl should not be taken in pregnancy, especially the first trimester, and during breast feeding unless the expected benefit is thought to outweigh any possible risk and only on medical advice.
No studies on the effects of Bisacodyl on the ability to drive and use machines have been performed.
However, patients should be advised that due to a vasovagal response (e.g. to abdominal spasm) they may experience dizziness and / or syncope. If patients experience abdominal spasm they should avoid potentially hazardous tasks such as driving or operating machinery.
The most commonly reported adverse reactions during treatment are abdominal pain and diarrhoea.
Adverse events have been ranked under headings of frequency using the following convention: Very common (≥ 1/10); common (≥ 1/100, < 1/10); uncommon (≥ 1/1000, <1/100); rare (≥ 1/10000, <1/1000); very rare (<1/10000).
Immune system disorders
Rare: anaphylactic reactions, angioedema, hypersensitivity.
Metabolism and nutrition disorders
Rare: dehydration.
Nervous system disorders
Uncommon: dizziness.
Rare: Syncope.
Dizziness and syncope occurring after taking bisacodyl appear to be consistent with a vasovagal response (e.g. to abdominal spasm, defaecation).
Gastrointestinal disorders
Uncommon: haematochezia (blood in stool), vomiting, abdominal discomfort, anorectal discomfort.
Common: abdominal cramps, abdominal pain, diarrhoea and nausea.
Rare: colitis including ischaemic colitis.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit / risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Symptoms
If high doses are taken watery stools (diarrhoea), abdominal cramps and a clinically significant loss of fluid, potassium and other electrolytes can occur.
Laxatives when taken in chronic overdose may cause chronic diarrhoea, abdominal pain, hypokalaemia, secondary hyperaldosteronism and renal calculi. Renal tubular damage, metabolic alkalosis and muscle weakness secondary to hypokalaemia have also been described in association with chronic laxative abuse.
Therapy
After ingestion of oral forms of Bisacodyl, absorption can be minimised or prevented by inducing vomiting or gastric lavage. Replacement of fluids and correction of electrolyte imbalance (particularly potassium) may be required. This is especially important in the elderly and the young.
Administration of antispasmodics may be of value.
Ask anything about Bisacodyl 5mg Tablets. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.